These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22563404)

  • 1. In vitro proliferation of adult human beta-cells.
    Rutti S; Sauter NS; Bouzakri K; Prazak R; Halban PA; Donath MY
    PLoS One; 2012; 7(4):e35801. PubMed ID: 22563404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of sorted human and rat beta cells.
    Parnaud G; Bosco D; Berney T; Pattou F; Kerr-Conte J; Donath MY; Bruun C; Mandrup-Poulsen T; Billestrup N; Halban PA
    Diabetologia; 2008 Jan; 51(1):91-100. PubMed ID: 17994216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice.
    Kumari P; Nakata M; Zhang BY; Otgon-Uul Z; Yada T
    Biochem Biophys Res Commun; 2018 May; 499(3):618-625. PubMed ID: 29601817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?
    Hansen AM; Bödvarsdottir TB; Nordestgaard DN; Heller RS; Gotfredsen CF; Maedler K; Fels JJ; Holst JJ; Karlsen AE
    Diabetologia; 2011 Jun; 54(6):1379-87. PubMed ID: 21347622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation.
    Lee YS; Lee C; Choung JS; Jung HS; Jun HS
    Diabetes; 2018 Dec; 67(12):2601-2614. PubMed ID: 30257975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.
    Gleizes C; Kreutter G; Abbas M; Kassem M; Constantinescu AA; Boisramé-Helms J; Yver B; Toti F; Kessler L
    J Cell Mol Med; 2016 Feb; 20(2):231-42. PubMed ID: 26607759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucagon-like peptide-1 analogue liraglutide promotes autophagy through the modulation of 5'-AMP-activated protein kinase in INS-1 β-cells under high glucose conditions.
    Miao X; Gu Z; Liu Y; Jin M; Lu Y; Gong Y; Li L; Li C
    Peptides; 2018 Feb; 100():127-139. PubMed ID: 28712893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
    J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling pathways implicated in the stimulation of beta-cell proliferation by extracellular matrix.
    Parnaud G; Hammar E; Ribaux P; Donath MY; Berney T; Halban PA
    Mol Endocrinol; 2009 Aug; 23(8):1264-71. PubMed ID: 19443607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells.
    Lefebvre VH; Otonkoski T; Ustinov J; Huotari MA; Pipeleers DG; Bouwens L
    Diabetes; 1998 Jan; 47(1):134-7. PubMed ID: 9421388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival.
    Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
    Mol Cell Endocrinol; 2016 Nov; 436():102-13. PubMed ID: 27465830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells.
    Fang D; Huang Z; Guan H; Liu J; Yao B; Xiao H; Li Y
    Mol Med Rep; 2012 Jan; 5(1):233-8. PubMed ID: 21964769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival.
    Liu Z; Stanojevic V; Avadhani S; Yano T; Habener JF
    Diabetologia; 2011 Aug; 54(8):2067-76. PubMed ID: 21567300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways.
    Boutant M; Ramos OH; Tourrel-Cuzin C; Movassat J; Ilias A; Vallois D; Planchais J; Pégorier JP; Schuit F; Petit PX; Bossard P; Maedler K; Grapin-Botton A; Vasseur-Cognet M
    PLoS One; 2012; 7(1):e30847. PubMed ID: 22292058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.
    Klinger S; Poussin C; Debril MB; Dolci W; Halban PA; Thorens B
    Diabetes; 2008 Mar; 57(3):584-93. PubMed ID: 18025410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.
    Huang C; Yuan L; Cao S
    Int J Mol Med; 2015 Jul; 36(1):173-85. PubMed ID: 25976560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.